Rhythm Pharmaceuticals In... (RYTM)
NASDAQ: RYTM
· Real-Time Price · USD
101.75
-0.37 (-0.36%)
At close: Sep 08, 2025, 10:34 AM
Rhythm Pharmaceuticals Revenue
Rhythm Pharmaceuticals reported an annual revenue of $130.13M, reflecting a 68.06% growth. For the quarter ending June 30, 2025, Rhythm Pharmaceuticals generated $48.5M in revenue.
Revenue (ttm)
130.13M
Revenue Growth
68.06%
Price / Sales Ratio
26.24
Revenue / Employee
459.81K
Employees
283
Market Cap
6.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 130.13M | +68.06% |
| Dec 31, 2023 | 77.43M | +227.56% |
| Dec 31, 2022 | 23.64M | +649.46% |
| Dec 31, 2021 | 3.15M | +Infinity% |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |
| Dec 31, 2012 | 0 | n/a |